ClinicalTrials.Veeva

Menu

Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Completed

Conditions

Vaccine Hesitancy

Treatments

Other: Perceptions and attitudes towards COVID-19 and COVID-19 vaccine

Study type

Observational

Funder types

Other

Identifiers

NCT05532592
KY2022-138-B

Details and patient eligibility

About

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Full description

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Questionnaire items including demographic characteristics, understanding of COVID-19, attitude toward COVID-19 vaccine. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Enrollment

449 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age ≥ 18
  2. recipients after liver transplantation surgery

Exclusion criteria

  1. Incomplete data (missing questionnaire information), such as lack of age, gender, indication for transplantation, time after transplantation and other indicators
  2. loss to follow-up
  3. COVID-19 vaccination before liver transplantation

Trial design

449 participants in 2 patient groups

no hesitancy group (NHG)
Description:
Participants who got vaccine after transplantation or were willing to be vaccinated.
Treatment:
Other: Perceptions and attitudes towards COVID-19 and COVID-19 vaccine
hesitancy group (HG)
Description:
Participants who were uncertain or refused to be vaccinated.
Treatment:
Other: Perceptions and attitudes towards COVID-19 and COVID-19 vaccine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems